Organization Overview
Alternative names
13c5-calcium-l-leucovorin (1 trial)
bortezomib (velcade) (1 trial)
capecitabine (xeloda) (4 trials)
dexmedetomidine (precedex) (2 trials)
docetaxel (taxotere) (5 trials)
fluorouracil (efudex) (4 trials)
acetaminophen (tylenol) (1 trial)
autologous peripheral blood mononuclear cells (1 trial)
bacille calmette-guerin (1 trial)
dactinomycin (cosmegen) (1 trial)
doxorubicin (Doxil) (3 trials)
doxycycline (vibramycin) (1 trial)
Acute Disease (Phase 3)
Adenocarcinoma (Phase 2)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Critical Illness (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
End Stage Liver Disease (Phase 4)
Esophageal Neoplasms (Phase 2)
Gastrointestinal Neoplasms (Phase 4)
Glioblastoma (Phase 3)
Heart Diseases (Phase 2)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hypertension, Portal (Phase 4)
Hypotension (Phase 2)
Leukemia (Phase 3)
Liver Diseases (Phase 4)
Multiple Myeloma (Phase 3)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Neuroendocrine Tumors (Phase 2)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Postoperative Complications (Phase 3)
Rectal Neoplasms (Phase 3)
Salivary Gland Neoplasms (Phase 2)
Vitamin D Deficiency (Phase 4)
